Mechanisms of prescription drug diversion among drug-involved club- and street-based populations - PubMed (original) (raw)
Mechanisms of prescription drug diversion among drug-involved club- and street-based populations
James A Inciardi et al. Pain Med. 2007 Mar.
Abstract
Objective: Prescription drug diversion involves the unlawful channeling of regulated pharmaceuticals from legal sources to the illicit marketplace, and can occur along all points in the drug delivery process, from the original manufacturing site to the wholesale distributor, the physician's office, the retail pharmacy, or the patient. However, empirical data on diversion are limited.
Method: In an attempt to develop a better understanding of how specific drug-using populations are diverting prescription opioids and other medications, or obtaining controlled drugs that have already been diverted, qualitative interviews and focus group data were collected on four separate populations of prescription drug abusers in Miami, Florida--club drug users, street-based illicit drug users, methadone maintenance patients, and HIV positive individuals who abuse and/or divert drugs.
Results: Sources of abused prescription drugs cited by focus group participants were extremely diverse, including their physicians and pharmacists; parents and relatives; "doctor shopping"; leftover supplies following an illness or injury; personal visits to Mexico, South America and the Caribbean; prescriptions intended for the treatment of mental illness; direct sales on the street and in nightclubs; pharmacy and hospital theft; through friends or acquaintances; under-the-door apartment flyers advertising telephone numbers to call; and "stealing from grandma's medicine cabinet."
Conclusion: While doctor shoppers, physicians and the Internet receive much of the attention regarding diversion, the data reported in this paper suggest that there are numerous active street markets involving patients, Medicaid recipients and pharmacies as well. In addition, there are other data which suggest that the contributions of residential burglaries, pharmacy robberies and thefts, and "sneak thefts" to the diversion problem may be understated.
Figures
Figure 1
Police and regulatory agency perceptions of the primary sources of prescription drug diversion.
Similar articles
- Prescription opioid abuse and diversion in an urban community: the results of an ultrarapid assessment.
Inciardi JA, Surratt HL, Cicero TJ, Beard RA. Inciardi JA, et al. Pain Med. 2009 Apr;10(3):537-48. doi: 10.1111/j.1526-4637.2009.00603.x. Pain Med. 2009. PMID: 19416440 Free PMC article. - Prescription opioid use, misuse, and diversion among street drug users in New York City.
Davis WR, Johnson BD. Davis WR, et al. Drug Alcohol Depend. 2008 Jan 1;92(1-3):267-76. doi: 10.1016/j.drugalcdep.2007.08.008. Epub 2007 Oct 29. Drug Alcohol Depend. 2008. PMID: 17913395 Free PMC article. - The Diversion of Prescription Opioid Analgesics.
Inciardi JA, Surratt HL, Lugo Y, Cicero TJ. Inciardi JA, et al. Law Enforc Exec Forum. 2007 Nov;7(7):127-141. Law Enforc Exec Forum. 2007. PMID: 25267926 Free PMC article. - Prevention of alcohol and drug abuse: what works?
Kumpfer KL. Kumpfer KL. Subst Abus. 2002 Sep;23(3 Suppl):25-45. Subst Abus. 2002. PMID: 23580986 Review. - Extent of illicit drug use and dependence, and their contribution to the global burden of disease.
Degenhardt L, Hall W. Degenhardt L, et al. Lancet. 2012 Jan 7;379(9810):55-70. doi: 10.1016/S0140-6736(11)61138-0. Lancet. 2012. PMID: 22225671 Review.
Cited by
- Antiretroviral drug diversion links social vulnerability to poor medication adherence in substance abusing populations.
Tsuyuki K, Surratt HL. Tsuyuki K, et al. AIDS Behav. 2015 May;19(5):869-81. doi: 10.1007/s10461-014-0969-7. AIDS Behav. 2015. PMID: 25893656 Free PMC article. - Utilizing Administrative Data to Focus Quality Improvement Efforts for Opioid Prescribing in an Integrated Health System.
Ramar P, Roellinger DL, Ebbert JO, Lovely JK, Philpot LM. Ramar P, et al. EGEMS (Wash DC). 2018 May 10;6(1):6. doi: 10.5334/egems.203. EGEMS (Wash DC). 2018. PMID: 29881764 Free PMC article. - An analysis of the number of multiple prescribers for opioids utilizing data from the California Prescription Monitoring Program.
Wilsey BL, Fishman SM, Gilson AM, Casamalhuapa C, Baxi H, Lin TC, Li CS. Wilsey BL, et al. Pharmacoepidemiol Drug Saf. 2011 Dec;20(12):1262-8. doi: 10.1002/pds.2129. Epub 2011 Mar 29. Pharmacoepidemiol Drug Saf. 2011. PMID: 21448897 Free PMC article. - Prevalence of substance misuse in new patients in an outpatient psychiatry clinic using a prescription monitoring program.
Sowa EM, Fellers JC, Raisinghani RS, Santa Cruz MR, Hidalgo PC, Lee MS, Martinez LA, Keller AE, Clayton AH. Sowa EM, et al. Prim Care Companion CNS Disord. 2014;16(1):PCC.13m01566. doi: 10.4088/PCC.13m01566. Epub 2014 Jan 2. Prim Care Companion CNS Disord. 2014. PMID: 24940523 Free PMC article. - The Impact of Drugs and Substance Abuse on Viral Pathogenesis-A South African Perspective.
Ratshisusu L, Simani OE, Blackard JT, Selabe SG. Ratshisusu L, et al. Viruses. 2024 Jun 17;16(6):971. doi: 10.3390/v16060971. Viruses. 2024. PMID: 38932263 Free PMC article. Review.
References
- Inciardi JA, Surratt HL, Kurtz SP, Burke JJ. The diversion of prescription drugs by health care workers in Cincinnati, Ohio. Subst Use Misuse. 2006;41:1–10. - PubMed
- Inciardi JA, Goode JL. OxyContin and prescription drug abuse. Consumers Res. 2003;86(7):17–21.
- Meier B, Killer Pain. A “Wonder” Drug's Trail of Addiction and Death. Emmaus, PA: Rodale Press; 2003.
- Nagel LM, Good PM. DEA—Industry Communicator Oxycontin Special. Washington, DC: U.S. Department of Justice, Drug Enforcement Administration, Office of Diversion Control; 2001.
- National Institute on Drug Abuse. Prescription Drugs: Abuse and Addiction. Bethesda, MD: NIDA Research Report; 2001. NIH publication 01-4881.
Publication types
MeSH terms
Substances
Grants and funding
- R01 DA021330/DA/NIDA NIH HHS/United States
- R01-DA13131/DA/NIDA NIH HHS/United States
- R01-DA14854/DA/NIDA NIH HHS/United States
- R01 DA019048-05/DA/NIDA NIH HHS/United States
- R01 DA013131/DA/NIDA NIH HHS/United States
- R01 DA014854/DA/NIDA NIH HHS/United States
- R01 DA021330-03/DA/NIDA NIH HHS/United States
- R01 DA021330-04/DA/NIDA NIH HHS/United States
- R01 DA019048/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous